跳至主要内容
临床试验/JPRN-UMIN000008186
JPRN-UMIN000008186招募中未知

eutralizing antibody of Interferon beta on multiple sclerosis (Multi-center clinical studies) - Neutralizing antibody of IFN-beta on MS (Multi-center clinical studies)

Yokohama City University0 个研究点目标入组 100 人开始时间: 2012年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Not MS patients

研究者

相似试验

进行中(未招募)
不适用
eutralizing Antibodies to Interferon beta in patients treated with Rebif New Formulation - NAb development with RNFIFNß-naïve patients fulfilling Poser or McDonald criteria for CDMS or MS and in whom a decision has been made to initiate treatment with RNF (Rebif New Formulation).MedDRA version: 9.1Level: LLTClassification code 10028245Term: Multiple sclerosis
EUCTR2008-008554-23-SEThe Multiple Sclerosis Research Group, Department of Clinical Neuroscience100
进行中(未招募)
不适用
REsPons på interferon-Alfa hos InterfeRon-ß-neutraliserende antistof-positive patienter med multipel sklerose - REPAIRMedDRA version: 12.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMultiple Sclerosis
EUCTR2009-016824-29-DKDansk Multipel Sclerose Center10
进行中(未招募)
1 期
Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patientsSARS-CoV 2 infection characterized by a National Early Warning Score lower or equal to 2 and symptoms present for less than 7 daysMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862MedDRA version: 20.0Level: PTClassification code 10070255Term: Coronavirus test positiveSystem Organ Class: 10022891 - Investigations
EUCTR2020-003872-42-ITIstituto di Farmacologia Traslazionale - CNR60
进行中(未招募)
不适用
Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy - Interferon beta dose and antibodyMultiple sclerosis
EUCTR2005-001008-37-SESahlgrenska University Hospital100
已完成
不适用
Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosismultiple sclerosis
JPRN-UMIN000005797Department of Neurology, Tohoku University School of Medicine100